Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GLAXF source : Www.biospace.com save search
Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors
Published: 2023-11-28 (Crawled : 21:00) - biospace.com/
UNCY | $1.08 -0.92% -0.93% 230K
|
Professional, Scientific, and T...
|
| O: -6.96%
H: 7.9%
C: 3.35%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.51%
H: 0.96%
C: 0.54%
GERN | $3.69 -1.07% -1.08% 8.2M
|
Health Technology
|
| O: -1.05%
H: 2.65%
C: 1.06%
corporation
NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
|
| O: 40.0%
H: 0.0%
C: -25.71%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.89%
H: 1.97%
C: -0.46%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.64%
H: 0.82%
C: 0.38%
NRBO | $3.325 -3.34% -3.46% 21K
|
Health Technology
|
| O: 4.76%
H: 0.0%
C: -3.61%
pharmaceuticals
Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including at the 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 15:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.57%
H: 0.22%
C: -1.98%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -2.63%
ZNTL | $12.915 2.99% 670K
|
Health Technology
|
| O: -0.23%
H: 0.18%
C: -1.43%
asco positive cancer meeting
Zentalis Announces Preclinical Data Supporting Cyclin E1 As A Predictive Marker For Azenosertib Treatment At AACR Annual Meeting 2023
Published: 2023-04-17 (Crawled : 14:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.88%
H: 3.85%
C: 3.85%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.24%
H: 0.01%
C: -0.77%
ZNTL | $12.915 2.99% 670K
|
Health Technology
|
| O: 1.54%
H: 8.37%
C: 5.89%
treatment preclinical meeting
ViiV Healthcare to present first head-to-head data for long-acting HIV treatment Cabenuva against daily oral Biktarvy at CROI 2023
Published: 2023-02-14 (Crawled : 15:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.74%
H: 2.37%
C: 1.92%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.23%
H: 0.25%
C: -0.84%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.33%
H: 0.06%
C: -0.14%
treatment hiv biktarvy
SpyBiotech Appoints Industry Veteran Eddie Gray as Chair of its Board of Directors
Published: 2023-02-13 (Crawled : 11:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.73%
H: 0.0%
C: -1.43%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.61%
H: 0.47%
C: 0.47%
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -3.67%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.26%
H: 2.97%
C: 2.7%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.85%
H: 0.31%
C: -0.45%
BHVN | News 0 d | $38.99 -7.52% 0.0% 3.4M
|
Health Technology
|
| O: -0.48%
H: 4.49%
C: 3.24%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.74%
H: 4.84%
C: 3.88%
BEAM | $23.9 -1.69% -1.72% 4.5M
|
Health Technology
|
| O: 0.21%
H: 4.84%
C: 2.99%
financial results
Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HLN | $8.21 0.98% 0.0% 3.5M
|
n/a
|
| O: 0.16%
H: 1.79%
C: 0.16%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.68%
H: 0.0%
C: -0.27%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 3.11%
H: 0.88%
C: 0.02%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.72%
H: 0.39%
C: -0.83%
BHVN | News 0 d | $38.99 -7.52% 0.0% 3.4M
|
Health Technology
|
| O: 1.81%
H: 3.08%
C: -0.65%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
BEAM | $23.9 -1.69% -1.72% 4.5M
|
Health Technology
|
| O: 3.25%
H: 1.41%
C: -2.48%
ARVN | $34.71 1.23% 780K
|
Health Technology
|
| O: 1.49%
H: 3.25%
C: 1.68%
results
ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV
Published: 2022-10-25 (Crawled : 15:20) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.27%
H: 0.0%
C: -2.17%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.59%
H: 1.21%
C: 0.71%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.57%
H: 1.16%
C: 0.94%
offering treatment antibody hiv potential positive
Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -12.81%
H: 8.43%
C: 5.21%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -8.67%
H: 2.89%
C: 2.14%
FULC | $6.79 -3.82% 390K
|
Health Technology
|
| O: -10.82%
H: 17.27%
C: 9.39%
therapeutics update results
Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update
Published: 2022-07-28 (Crawled : 15:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: -2.13%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.54%
H: 0.91%
C: 0.14%
sdc-1801 application trial update
Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding
Published: 2022-07-12 (Crawled : 12:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.87%
H: 0.0%
C: -3.01%
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.28%
H: 0.12%
C: -1.68%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
health funding
Contraceptives Drugs Market Size Will Observe Substantial Growth by 2030 Wilmington, Delaware, United States: Childbearing at an early age has become an issue of concern and to prevent the deaths cause...
Published: 2022-06-23 (Crawled : 06:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.14%
H: 0.14%
C: -2.96%
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.31%
H: 0.59%
C: 0.54%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: 0.0%
contraceptives growth market
Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President
Published: 2022-06-16 (Crawled : 14:20) - biospace.com/
XLO | $1.16 -9.38% -10.34% 340K
|
Professional, Scientific, and T...
|
| O: 1.32%
H: 1.73%
C: -3.9%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.07%
H: 2.34%
C: 0.33%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
SNDX | $20.78 1.42% 550K
|
Health Technology
|
| O: -2.65%
H: 0.76%
C: 0.06%
SURF | $1.07 -0.93% -1.41% 0
|
Health Technology
|
| O: -1.96%
H: 0.67%
C: -5.33%
MRSN | $3.255 -2.55% -2.61% 2.4M
|
Health Technology
|
| O: -3.79%
H: 3.28%
C: 3.28%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: -1.32%
H: 0.01%
C: -5.65%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -2.17%
H: 1.76%
C: 1.46%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -4.37%
H: 0.14%
C: -3.76%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: -4.31%
H: 0.9%
C: -8.11%
BIIB | $193.75 1.7% 1M
|
Health Technology
|
| O: -2.0%
H: 0.29%
C: -0.93%
AGIO | News | $29.07 -1.22% 470K
|
Health Technology
|
| O: -3.38%
H: 4.35%
C: -3.22%
therapeutics
Global Panic Disorders Market Insights | Size | Shares | Trends | Growth | Industry Analysis [2020-2030] Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. PET-CT Scanner Devices Market: Competitive Landscape Analysis With Forecast by 2031 Wilmington, Delaware: According to the report, the global PET-CT scanner devices market was valued over US$ 200 Mn in 2020 and is projected to expand at a CAGR of ~3% from 2021 to 2031. Portal Hypertension Market Insights | Current Trends | Growth Opportunity | Global Industry Analysis [2020-2030] At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. Spatial Genomics & Transcriptomics Market to Experience Significant Growth by 2027 Wilmington, Delaware: The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. Teleradiology Services Market to Make Great Impact in Near Future by 2031 Wilmington, Delaware: According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. Anti-depressants Drugs and Therapies Market to Witness a Pronounce Growth by 2025 Wilmington, Delaware: Anti-depressants medications lower the symptoms of depression, dysthymia, chronic depression, and anxiety disorders. B-Cell Non-Hodgkin’s Lymphoma (NHL) Market to Offer Ample Growth Opportunities by 2027 Wilmington, Delaware: Non-Hodgkin’s lymphoma is a group of heterogeneous proliferative malignancies. Heightening Healthcare Spending Opening Growth Avenues for Collateral Ligament Stabilizer System Market, Reaching US$ 3.5 Billion in 2032: Fact.MR Study Fact.MR – A Market Research and Competitive Intelligence Provider: The global collateral ligament stabilizer system market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.1%, concludes a recently published report by Fact.MR. Breast Cancer Liquid Biopsy Market Trends, Growth, Analysis and Future Scope, 2026 Wilmington, Delaware: A biopsy is a tissue or cell sample taken from any part of the patient’s body and examined in the lab for the detection of cancer. Cerebral Palsy Market Size, Shares, Trends and Growth | Global Industry Analysis [2020-2030] The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. Continuous Glucose Monitoring Market: Competitive Research and Precise Outlook 2021 to 2028 Wilmington, Delaware: The global continuous glucose monitoring market depicts the presence of a large competitive vendor landscape, says Transparency Market Research on the basis of a newly research report. Crow’s Feet Market Key Trends and Opportunity Analysis up to 2026 Albany NY, United States: The demand within the global crow’s feet market has been escalating on account of vital advancements in the field of dermatology in recent times. HIV Associated Lipodystrophy Syndrome Market Insights | Global Industry Analysis [2020-2030] HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus -infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Global Mail Service Pharmacy Market | Size | Shares | Trends | Growth | Forecast [2020-2030]
Published: 2022-06-03 (Crawled : 06:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.4%
H: 4.05%
C: -1.35%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -2.25%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
NBIX M | $132.03 -0.39% -0.39% 560K
|
Health Technology
|
| O: 2.29%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
lipodystrophy treatment research system active services report service growing hiv profitable hypertension genomics expected virus approval cancer growth group market breast cancer infections
MacroGenics Announces Appointment of William Heiden to Board of Directors
Published: 2022-05-23 (Crawled : 21:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.85%
H: 4.48%
C: 4.48%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
MGNX | $15.74 -2.05% 540K
|
Health Technology
|
| O: 0.0%
H: 3.52%
C: -0.5%
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 1.74%
H: 1.52%
C: -5.14%
Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments
Published: 2022-04-18 (Crawled : 14:00) - biospace.com/
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.2%
H: 0.8%
C: 0.2%
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: -0.28%
H: 1.71%
C: -6.97%
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn
Published: 2022-04-13 (Crawled : 09:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.76%
H: 0.35%
C: 0.35%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.24%
H: 0.45%
C: 0.39%
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 37.85%
H: 0.9%
C: 0.5%
Oak Hill Bio Announces Formation of Board of Directors
Published: 2022-04-12 (Crawled : 13:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.07%
H: 0.47%
C: -0.4%
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -3.41%
H: 1.22%
C: 0.49%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
SNY | News | $46.385 2.19% 3M
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living With HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kg
Published: 2022-03-29 (Crawled : 18:00) - biospace.com/
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: -1.87%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 1.35%
H: 0.15%
C: -2.33%
JNJ | News | $147.895 1.48% 5.8M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
fda approval hiv order
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.